|View printer-friendly version|
Current estimates are that the company should achieve guidance in all areas
"ZixCorp had a solid quarter in Q1, achieving all of its guidance, despite
tough economic times," said Spurr. "Preliminary estimates for revenue are
that we should meet our guidance of
"In its Email Encryption business, ZixCorp recorded
About the company's e-Prescribing business, Spurr said, "Our PocketScript(R) business achieved the top end of the e-Prescribing deployment guidance for the first quarter with approximately 350 deployments. ZixCorp processed over 2.5 million scripts in the quarter, an increase of over 12 percent compared with Q1 2008. We also released an upgrade to our PocketScript e-Prescribing service, which not only delivered improved functionality to our users but also kept us current with the ever-increasing certification requirements."
Spurr concluded, "To repeat, the Company had a solid quarter in Q1 and our overall prospects remain healthy."
ZixCorp to Announce First Quarter 2009 Results on
The company's first quarter 2009 operating results will be released after
close of the U.S. financial markets on
A live Webcast of the conference call will be available on the investor
relations portion of ZixCorp's Web site at http://investor.zixcorp.com.
Alternatively, participants can listen to the conference call by dialing
617-614-6207 or toll-free 800-798-2884 and entering access code 15222301. An
audio replay of the conference will be available until
Safe Harbor Statement for ZixCorp
The following is a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995. Many of the foregoing statements by Mr. Spurr are forward-looking statements, not a guarantee of future performance, and involve substantial risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements. These risks and uncertainties include, but are not limited to, the following: the fact that the preliminary financial results included in this press release could be subject to change based on adjustments that are deemed appropriate by the Company during the process of finalizing its quarterly financial statements; the Company's continued operating losses and its PocketScript e-Prescribing service's use of cash resources; the Company's ability to achieve broad market acceptance for the Company's products and services, including the Company's ability to enter into new or expand existing sponsorship agreements for its PocketScript e-Prescribing business and the Company's ability to continue realizing acceptance of its Email Encryption business in its core markets of healthcare and financial and to achieve market acceptance of its Email Encryption business in other markets; the Company's ability to maintain existing and generate other revenue opportunities, including fees for scripts written or value added services for its payor customers from its PocketScript e-Prescription business; the Company's ability to establish and maintain strategic and OEM relationships to gain customers and grow revenues, particularly in its Email Encryption business; the expected increase in competition in the Company's Email Encryption and e-Prescription businesses; and the Company's ability to successfully and timely introduce new Email Encryption and e-Prescription products and services or related products and services and implement technological changes. Further details pertaining to such risks and uncertainties may be found in the Company's public filings with the SEC.
Public Relations, Geoff Bibby, +1-214-370-2241
Peter Wilensky, +1-214-515-7357
Web Site: http://www.zixcorp.com